Samsung Pharmaceutical Reports Consolidated Operating Loss of 18.1 Billion KRW Last Year... Returns to Deficit

[Asia Economy Reporter Song Seung-seop] Samsung Pharmaceutical announced on the 14th that it recorded an operating loss of 18.13983 billion KRW on a consolidated basis last year, turning to a deficit compared to the previous year. Last year's sales amounted to 54.9113 billion KRW, an increase of 13.7% compared to the previous year. The company explained that the profit margin decreased due to an increase in the cost of goods sold ratio caused by temporary factory rental fees incurred during the sale of the No. 1 factory and inventory asset disposal losses due to product recall measures by the Ministry of Food and Drug Safety.

This content was produced with the assistance of AI translation services.